首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   320252篇
  免费   16719篇
  国内免费   2163篇
耳鼻咽喉   4075篇
儿科学   8882篇
妇产科学   6895篇
基础医学   46349篇
口腔科学   7698篇
临床医学   25505篇
内科学   69487篇
皮肤病学   7989篇
神经病学   27895篇
特种医学   10053篇
外国民族医学   112篇
外科学   40244篇
综合类   5204篇
现状与发展   1篇
一般理论   74篇
预防医学   27656篇
眼科学   6431篇
药学   23353篇
中国医学   1570篇
肿瘤学   19661篇
  2023年   1627篇
  2022年   1938篇
  2021年   5280篇
  2020年   3033篇
  2019年   5434篇
  2018年   10642篇
  2017年   7039篇
  2016年   6491篇
  2015年   7077篇
  2014年   8193篇
  2013年   12279篇
  2012年   20021篇
  2011年   20021篇
  2010年   10461篇
  2009年   8468篇
  2008年   17161篇
  2007年   18250篇
  2006年   16868篇
  2005年   16401篇
  2004年   15353篇
  2003年   14198篇
  2002年   13406篇
  2001年   11357篇
  2000年   11442篇
  1999年   10005篇
  1998年   2663篇
  1997年   2014篇
  1996年   1549篇
  1995年   1370篇
  1994年   1204篇
  1993年   1099篇
  1992年   5416篇
  1991年   4775篇
  1990年   4529篇
  1989年   4225篇
  1988年   3835篇
  1987年   3624篇
  1986年   3338篇
  1985年   2961篇
  1984年   2120篇
  1983年   1764篇
  1982年   1007篇
  1979年   1614篇
  1978年   1029篇
  1974年   1162篇
  1973年   1200篇
  1972年   1110篇
  1971年   1084篇
  1970年   1014篇
  1969年   1046篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.

Background

Available models for predicting lymph node invasion (LNI) in prostate cancer (PCa) patients undergoing radical prostatectomy (RP) might not be applicable to men diagnosed via magnetic resonance imaging (MRI)-targeted biopsies.

Objective

To assess the accuracy of available tools to predict LNI and to develop a novel model for men diagnosed via MRI-targeted biopsies.

Design, setting, and participants

A total of 497 patients diagnosed via MRI-targeted biopsies and treated with RP and extended pelvic lymph node dissection (ePLND) at five institutions were retrospectively identified.

Outcome measurements and statistical analyses

Three available models predicting LNI were evaluated using the area under the receiver operating characteristic curve (AUC), calibration plots, and decision curve analyses. A nomogram predicting LNI was developed and internally validated.

Results and limitations

Overall, 62 patients (12.5%) had LNI. The median number of nodes removed was 15. The AUC for the Briganti 2012, Briganti 2017, and MSKCC nomograms was 82%, 82%, and 81%, respectively, and their calibration characteristics were suboptimal. A model including PSA, clinical stage and maximum diameter of the index lesion on multiparametric MRI (mpMRI), grade group on targeted biopsy, and the presence of clinically significant PCa on concomitant systematic biopsy had an AUC of 86% and represented the basis for a coefficient-based nomogram. This tool exhibited a higher AUC and higher net benefit compared to available models developed using standard biopsies. Using a cutoff of 7%, 244 ePLNDs (57%) would be spared and a lower number of LNIs would be missed compared to available nomograms (1.6% vs 4.6% vs 4.5% vs 4.2% for the new nomogram vs Briganti 2012 vs Briganti 2017 vs MSKCC).

Conclusions

Available models predicting LNI are characterized by suboptimal accuracy and clinical net benefit for patients diagnosed via MRI-targeted biopsies. A novel nomogram including mpMRI and MRI-targeted biopsy data should be used to identify candidates for ePLND in this setting.

Patient summary

We developed the first nomogram to predict lymph node invasion (LNI) in prostate cancer patients diagnosed via magnetic resonance imaging-targeted biopsy undergoing radical prostatectomy. Adoption of this model to identify candidates for extended pelvic lymph node dissection could avoid up to 60% of these procedures at the cost of missing only 1.6% patients with LNI.  相似文献   
52.
53.
54.
55.
56.
57.
58.
59.
60.

Background

We have recently shown that human epididymis protein 4 (HE4) levels correlate with the severity of cystic fibrosis (CF) lung disease. However, there are no data on how HE4 levels alter in patients receiving CFTR modulating therapy.

Methods

In this retrospective clinical study, 3 independent CF patient cohorts (US-American: 29, Australian: 12 and Irish: 19 cases) were enrolled carrying at least one Class III CFTR CF-causing mutation (p.Gly551Asp) and being treated with CFTR potentiator ivacaftor. Plasma HE4 was measured by immunoassay before treatment (baseline) and 1–6?months after commencement of ivacaftor, and were correlated with FEV1 (% predicted), sweat chloride, C-reactive protein (CRP) and body mass index (BMI).

Results

After 1?month of therapy, HE4 levels were significantly lower than at baseline and remained decreased up to 6?months. A significant inverse correlation between absolute and delta values of HE4 and FEV1 (r?=??0.5376; P?<?.001 and r?=??0.3285; P?<?.001), was retrospectively observed in pooled groups, including an independent association of HE4 with FEV1 by multiple regression analysis (β?=??0.57, P?=?.019). Substantial area under the receiver operating characteristic curve (ROC-AUC) value was determined for HE4 when 7% mean change of FEV1 (0.722 [95% CI 0.581–0.863]; P?=?.029) were used as classifier, especially in the first 2?months of treatment (0.806 [95% CI 0.665–0.947]; P?<?.001).

Conclusions

This study shows that plasma HE4 levels inversely correlate with lung function improvement in CF patients receiving ivacaftor. Overall, this potential biomarker may be of value for routine clinical and laboratory follow-up of CFTR modulating therapy.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号